Shiro Ueno
Overview
Explore the profile of Shiro Ueno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
61
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ogawara D, Fukuda M, Ueno S, Ohue Y, Takemoto S, Mizoguchi K, et al.
Support Care Cancer
. 2015 Jun;
24(2):615-619.
PMID: 26108172
Background: This study was undertaken to analyze the characteristics of fever after cancer chemotherapy in order to reduce unnecessary medical care. Methods: Retrospectively, 1016 consecutive cycles of cancer chemotherapy were...
2.
Kawaguchi T, Kariya Y, Matsuda M, Kubo K, Miyauchi S, Kusumoto N, et al.
Intern Med
. 2014 Aug;
53(16):1847-51.
PMID: 25130123
A 63-year-old woman presented to our hospital with fever, purpura and pain in both legs and died 4 days after admission. Her blood smear and skin biopsy showed cylinder-like bodies...
3.
Umekita K, Umeki K, Miyauchi S, Ueno S, Kubo K, Kusumoto N, et al.
Mod Rheumatol
. 2013 Nov;
25(5):794-7.
PMID: 24252020
Anti-tumor necrosis factor (anti-TNF) biologics are effective in the treatment of rheumatoid arthritis (RA); however, it is still not clear whether this treatment promotes the development of malignancies such as...
4.
Umekita K, Hidaka T, Miyauchi S, Ueno S, Kubo K, Takajo I, et al.
Arthritis Care Res (Hoboken)
. 2013 Oct;
66(5):788-92.
PMID: 24127184
Objective: To investigate the response to and safety of anti–tumor necrosis factor (anti-TNF) therapy in human T lymphotropic virus type I (HTLV-I)–positive patients with rheumatoid arthritis (RA). Methods: Therapeutic response...
5.
Umekita K, Kaneko Y, Yorita K, Hashiba Y, Matsuda M, Miyauchi S, et al.
Rheumatology (Oxford)
. 2011 Nov;
51(3):580-2.
PMID: 22120458
No abstract available.
6.
Ueno S, Umeki K, Takajo I, Nagatomo Y, Kusumoto N, Umekita K, et al.
Int J Cancer
. 2011 Jul;
130(10):2318-26.
PMID: 21780105
High human T-lymphotropic virus Type 1 (HTLV-1) proviral DNA load (PVL) has been reported to be one risk factor for the development of adult T-cell leukemia/lymphoma (ATL). ATL is also...
7.
Umekita K, Miyauchi S, Ueno S, Takajo I, Kusumoto K, Hasuike S, et al.
Intern Med
. 2011 Jun;
50(11):1245-9.
PMID: 21628943
We report a case of rheumatoid arthritis (RA) with autoimmune hepatitis (AIH) and Sjogren syndrome (SjS) that was treated with the tumor necrosis factor (TNF) inhibitor, etanercept (ETN). Both RA...
8.
Takenouchi H, Umeki K, Sasaki D, Yamamoto I, Nomura H, Takajo I, et al.
Int J Cancer
. 2010 May;
128(6):1335-43.
PMID: 20473938
Few studies have specifically examined defective provirus in asymptomatic human T-lymphotropic virus Type 1 (HTLV-1) carriers and its relation to proviral DNA loads (PVLs). To assess the significance of defective...
9.
Kusumoto N, Kuroki M, Umekita K, Ueno S, Takajo I, Kai Y, et al.
Kansenshogaku Zasshi
. 2009 Jun;
83(3):261-5.
PMID: 19522311
A 25-year-old man undergoing splenectomy at 3 years of age to treat idiopathic thrombocytopenic purpura but no history of Streptococcus pneumonia vaccination, and reporting high fever, nausea, and headache developed...
10.
Kusumoto N, Kai Y, Kubo K, Miyauchi S, Umekita K, Ueno S, et al.
Nihon Naika Gakkai Zasshi
. 2009 May;
98(4):859-61.
PMID: 19432134
No abstract available.